A Study to Investigate Safety, Tolerability and Clinical Response With SAR441566 Compared With Placebo in Participants With Mild to Moderate Psoriasis
Clinical trial NCT05453942 · COMPLETED
Trial details
- NCT number
- NCT05453942
- Sponsor
- Sanofi
- Status
- COMPLETED
- Phase
- Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2022-07-12
- Primary completion
- 2023-02-09
- Enrollment
- 38
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.